Research Article
LRG1 May Accelerate the Progression of ccRCC via the TGF-β Pathway
Table 2
Clinical data of ccRCC patients.
| | ccRCC |
| Total | 528 |
| Sex | Male | 344 | Female | 184 | Unclear | 0 |
| Age | | | 21-40 | 25 | 41-60 | 239 | 61-80 | 240 | 81-100 | 23 | Unclear | 1 |
| Race | Caucasian | 459 | African American | 54 | Asian | 8 | Unclear | 8 |
| Stage | I | 263 | II | 57 | III | 123 | IV | 82 | Unclear | 4 |
| Grade | 1 | 14 | 2 | 229 | 3 | 206 | 4 | 76 | Unclear | 3 |
| Survival | Alive | 355 | Dead | 173 | Unclear | 0 |
| Survival time | | Days | Median | 1,195.5 | 25% | 545.25 | 75% | 1,928.25 | Min | 2 | Max | 4,537 |
|
|